PCDF (N = 6124) | ACDF (N = 6124) | OR (95% CI) | P | |
Frequency of narcotic use | ||||
30-day narcotic use, n (%) | 4208 (68.7) | 4338 (70.8) | 0.90 (0.83–0.98) | 0.01 |
60-day narcotic use, n (%) | 3990 (65.2) | 4185 (68.3) | 0.79 (0.79–0.94) | 0.0002 |
90-day narcotic use, n (%) | 3818 (62.3) | 4055 (66.2) | 0.84 (0.77–0.92) | <0.0001 |
120-day narcotic use, n (%) | 3674 (60.0) | 3943 (64.4) | 0.83 (0.76–0.90) | <0.0001 |
Level of narcotic use | ||||
30-day mean MME, mg | 1584.25 | 1384.64 | 1.19 (1.11–1.28) | <0.0001 |
60-day mean MME, mg | 1601.76 | 1395.59 | 1.20 (1.12–1.28) | <0.0001 |
90-day mean MME, mg | 1614.86 | 1402.07 | 1.21 (1.12–1.29) | <0.0001 |
120-day mean MME, mg | 1624.52 | 1408.09 | 1.21 (1.13–1.29) | <0.0001 |
Data presented as n (%) unless otherwise indicated.
ACDF, anterior discectomy and fusion; CSM, cervical spondylotic myelopathy; MME, morphine milligram equivalent; PCDF, posterior decompression and fusion.